TELADOC HEALTH, INC. Research and Development Expense
TELADOC HEALTH, INC. (TDOC) reported Research and Development Expense of $62.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-30
- TELADOC HEALTH, INC. research and development expense for the quarter ending 2026-06-30 was $62.86M, a 8.61% decline year-over-year.
- TELADOC HEALTH, INC. research and development expense for the quarter ending 2026-03-31 was $67.86M, a 2.99% decline year-over-year.
- TELADOC HEALTH, INC. research and development expense for the quarter ending 2025-12-31 was $71.61M, a 6.70% decline year-over-year.
- TELADOC HEALTH, INC. research and development expense for the quarter ending 2025-09-30 was $67.57M, a 6.65% decline year-over-year.
- TELADOC HEALTH, INC. research and development expense for fiscal 2025 was $277.92M, a 9.55% decline from fiscal 2024.
- TELADOC HEALTH, INC. research and development expense for fiscal 2024 was $307.27M, a 11.83% decline from fiscal 2023.
- TELADOC HEALTH, INC. research and development expense for fiscal 2023 was $348.52M, a 4.46% increase from fiscal 2022.
- TELADOC HEALTH, INC. research and development expense for fiscal 2022 was $333.63M, a 6.97% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $62.86M 10-Q · filed 2026-07-30 | $130.73M 10-Q · filed 2026-07-30 | $202.33M derived: sum of 3 quarters · filed 2026-07-30 | $269.91M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $67.86M 10-Q · filed 2026-04-30 | $139.47M derived: sum of 2 quarters · filed 2026-04-30 | $207.04M derived: sum of 3 quarters · filed 2026-04-30 | $275.83M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $71.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $139.18M derived: sum of 2 quarters · filed 2026-02-26 | $207.96M derived: sum of 3 quarters · filed 2026-07-30 | $277.92M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $67.57M 10-Q · filed 2025-10-30 | $136.36M derived: sum of 2 quarters · filed 2026-07-30 | $206.31M 10-Q · filed 2025-10-30 | $283.07M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $68.78M 10-Q · filed 2026-07-30 | $138.74M 10-Q · filed 2026-07-30 | $215.49M derived: sum of 3 quarters · filed 2026-07-30 | $287.88M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $69.96M 10-Q · filed 2026-04-30 | $146.71M derived: sum of 2 quarters · filed 2026-04-30 | $219.09M derived: sum of 3 quarters · filed 2026-04-30 | $295.84M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $76.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $149.13M derived: sum of 2 quarters · filed 2026-02-26 | $225.89M derived: sum of 3 quarters · filed 2026-02-26 | $307.27M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $72.38M 10-Q · filed 2025-10-30 | $149.13M derived: sum of 2 quarters · filed 2025-10-30 | $230.52M 10-Q · filed 2025-10-30 | $320.46M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $76.75M 10-Q · filed 2025-07-30 | $158.14M 10-Q · filed 2025-07-30 | $248.08M derived: sum of 3 quarters · filed 2026-02-26 | $332.37M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $81.39M 10-Q · filed 2025-05-01 | $171.33M derived: sum of 2 quarters · filed 2026-02-26 | $255.62M derived: sum of 3 quarters · filed 2026-02-26 | $342.92M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $89.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $174.23M derived: sum of 2 quarters · filed 2026-02-26 | $261.54M derived: sum of 3 quarters · filed 2026-02-26 | $348.52M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $84.29M 10-Q · filed 2024-10-31 | $171.60M derived: sum of 2 quarters · filed 2024-10-31 | $258.58M 10-Q · filed 2024-10-31 | $341.51M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $87.31M 10-Q · filed 2024-08-01 | $174.29M 10-Q · filed 2024-08-01 | $257.23M derived: sum of 3 quarters · filed 2025-02-27 | $341.81M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $86.98M 10-Q · filed 2024-04-26 | $169.92M derived: sum of 2 quarters · filed 2025-02-27 | $254.51M derived: sum of 3 quarters · filed 2025-02-27 | $333.20M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $82.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $167.52M derived: sum of 2 quarters · filed 2025-02-27 | $246.22M derived: sum of 3 quarters · filed 2025-02-27 | $333.63M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $84.59M 10-Q · filed 2023-10-27 | $87.81M 10-Q · filed 2022-11-02 | $163.29M derived: sum of 2 quarters · filed 2023-10-27 | $250.70M 10-Q · filed 2023-10-27 | $256.05M 10-Q · filed 2022-11-02 | $323.56M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-06-30 | $78.70M 10-Q · filed 2023-07-28 | $80.83M 10-Q · filed 2022-08-03 | $166.11M 10-Q · filed 2023-07-28 | $168.24M 10-Q · filed 2022-08-03 | $238.97M derived: sum of 3 quarters · filed 2024-02-23 | $319.23M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-03-31 | $87.41M 10-Q · filed 2023-05-02 | $160.28M derived: sum of 2 quarters · filed 2024-02-23 | $240.53M derived: sum of 3 quarters · filed 2024-02-23 | $321.29M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $72.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $153.12M derived: sum of 2 quarters · filed 2024-02-23 | $233.88M derived: sum of 3 quarters · filed 2024-02-23 | $311.88M 10-K · filed 2024-02-23 | |||
| 2021-09-30 | $80.25M 10-Q · filed 2022-11-02 | $161.01M derived: sum of 2 quarters · filed 2022-11-02 | $239.02M 10-Q · filed 2022-11-02 | $331.71M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $80.76M 10-Q · filed 2022-08-03 | $158.77M 10-Q · filed 2022-08-03 | $251.46M derived: sum of 3 quarters · filed 2023-03-01 | $281.42M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $78.01M 10-Q · filed 2022-05-02 | $170.71M derived: sum of 2 quarters · filed 2023-03-01 | $200.66M derived: sum of 3 quarters · filed 2023-03-01 | $223.69M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $92.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $122.66M derived: sum of 2 quarters · filed 2023-03-01 | $145.68M derived: sum of 3 quarters · filed 2023-03-01 | $164.94M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $29.96M 10-Q · filed 2021-11-01 | $52.99M derived: sum of 2 quarters · filed 2021-11-01 | $72.24M 10-Q · filed 2021-11-01 | $88.49M derived: sum of 4 quarters · filed 2021-11-01 | |||
| 2020-06-30 | $23.03M 10-Q · filed 2021-08-02 | $42.29M 10-Q · filed 2021-08-02 | $58.53M derived: sum of 3 quarters · filed 2021-08-02 | $74.28M derived: sum of 4 quarters · filed 2021-08-02 | |||
| 2020-03-31 | $19.26M 10-Q · filed 2021-05-03 | $35.50M derived: sum of 2 quarters · filed 2021-05-03 | $51.25M derived: sum of 3 quarters · filed 2021-05-03 | $67.91M derived: sum of 4 quarters · filed 2021-05-03 | |||
| 2019-12-31 | $16.25M 10-K · filed 2020-02-26 | $31.99M derived: sum of 2 quarters · filed 2020-11-06 | $48.66M derived: sum of 3 quarters · filed 2020-11-06 | $64.64M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $15.75M 10-Q · filed 2020-11-06 | $32.41M derived: sum of 2 quarters · filed 2020-11-06 | $48.40M 10-Q · filed 2020-11-06 | $61.94M derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $16.66M 10-Q · filed 2020-07-29 | $32.65M 10-Q · filed 2020-07-29 | $46.20M derived: sum of 3 quarters · filed 2020-07-29 | $59.77M derived: sum of 4 quarters · filed 2020-07-29 | |||
| 2019-03-31 | $15.99M 10-Q · filed 2020-04-29 | $29.53M derived: sum of 2 quarters · filed 2020-04-29 | $43.11M derived: sum of 3 quarters · filed 2020-04-29 | $57.46M derived: sum of 4 quarters · filed 2020-04-29 | |||
| 2018-12-31 | $13.54M 10-K · filed 2020-02-26 | $27.12M derived: sum of 2 quarters · filed 2020-02-26 | $41.47M derived: sum of 3 quarters · filed 2020-02-26 | $54.37M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $13.58M 10-K · filed 2020-02-26 | $27.93M derived: sum of 2 quarters · filed 2020-02-26 | $40.83M 10-Q · filed 2019-10-30 | $51.27M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | $14.35M 10-K · filed 2020-02-26 | $27.25M 10-Q · filed 2019-07-31 | $37.70M derived: sum of 3 quarters · filed 2020-02-26 | $47.66M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | $12.90M 10-K · filed 2020-02-26 | $23.35M derived: sum of 2 quarters · filed 2020-02-26 | $33.31M derived: sum of 3 quarters · filed 2020-02-26 | $40.85M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | $10.45M 10-K · filed 2019-02-27 | $20.41M derived: sum of 2 quarters · filed 2019-02-27 | $27.95M derived: sum of 3 quarters · filed 2019-02-27 | $34.46M 10-K · filed 2020-02-26 | |||
| 2017-09-30 | $9.96M 10-K · filed 2019-02-27 | $17.50M derived: sum of 2 quarters · filed 2019-02-27 | $24.01M 10-Q · filed 2018-11-01 | $29.91M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-06-30 | $7.54M 10-K · filed 2019-02-27 | $14.05M 10-Q · filed 2018-08-01 | $19.94M derived: sum of 3 quarters · filed 2019-02-27 | $25.81M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-03-31 | $6.51M 10-K · filed 2019-02-27 | $12.41M derived: sum of 2 quarters · filed 2019-02-27 | $18.27M derived: sum of 3 quarters · filed 2019-02-27 | $23.10M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | $5.89M 10-K · filed 2018-02-27 | $11.76M derived: sum of 2 quarters · filed 2018-02-27 | $16.59M derived: sum of 3 quarters · filed 2018-02-27 | $21.82M 10-K · filed 2019-02-27 | |||
| 2016-09-30 | $5.87M 10-K · filed 2018-02-27 | $10.70M derived: sum of 2 quarters · filed 2018-02-27 | $15.92M 10-Q · filed 2017-11-01 | $20.08M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $4.83M 10-K · filed 2018-02-27 | $10.05M 10-Q · filed 2017-08-02 | $14.21M derived: sum of 3 quarters · filed 2018-02-27 | $18.16M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $5.22M 10-K · filed 2018-02-27 | $9.38M derived: sum of 2 quarters · filed 2018-02-27 | $13.33M derived: sum of 3 quarters · filed 2018-02-27 | $16.53M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $8.10M derived: sum of 2 quarters · filed 2018-02-27 | $11.30M derived: sum of 3 quarters · filed 2018-02-27 | $14.21M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $3.94M 10-Q · filed 2016-10-27 | $7.14M derived: sum of 2 quarters · filed 2016-10-27 | $10.05M 10-Q · filed 2016-10-27 | $12.41M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $3.20M 10-Q · filed 2016-08-03 | $6.11M 10-Q · filed 2016-08-03 | $8.47M derived: sum of 3 quarters · filed 2017-03-01 | $10.43M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $2.91M 10-Q · filed 2016-05-10 | $5.26M derived: sum of 2 quarters · filed 2017-03-01 | $7.22M derived: sum of 3 quarters · filed 2017-03-01 | $9.29M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.32M derived: sum of 2 quarters · filed 2017-03-01 | $6.38M derived: sum of 3 quarters · filed 2017-03-01 | $7.57M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $1.96M 10-Q · filed 2015-11-02 | $4.02M derived: sum of 2 quarters · filed 2015-11-02 | $5.22M 10-Q · filed 2015-11-02 | ||||
| 2014-06-30 | $2.06M 10-Q · filed 2015-08-12 | $3.26M 10-Q · filed 2015-08-12 | |||||
| 2013-12-31 | $3.53M 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |